Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
February 20, 2023
On Sunday February 19th, the 36th Assembly of Heads of State and Government of the African Union elected Dr Jean Kaseya, a public health physician from the Democratic Republic of Congo, as the new Director General of the Africa Centres for Disease Control and Prevention (Africa CDC). Dr Kaseya will ...
Blog Post
December 14, 2022
It’s clear that COVID-19 oral antivirals are effective, and recent deals have made them even cheaper for African countries. But should these countries be investing in these medicines? Or would spending on alternative health services be better value for money? Unfortunately, there is very little avai...
Blog Post
December 02, 2022
An important debate is taking place in Europe right now on how to fund new antimicrobials. For months it has been speculated that the European Union may move towards implementing transferable exclusivity vouchers (TEVs). In response, 14 Member States wrote to the European Commission outlining why th...
Blog Post
November 23, 2022
This week is World Antimicrobial Awareness Week, a global campaign initiated by the World Health Organization (WHO) to improve awareness and understanding of AMR, yet only 44 percent of people have heard of AMR. We considered the portrayal of AMR in the media to determine how this might affect publi...
Blog Post
November 10, 2022
Laboratories are a fundamental component of health systems, critical in routine and emergency contexts for both disease surveillance and health services for communicable and non-communicable diseases. Investing in laboratories helps countries to create integrated and resilient health systems, achiev...
Blog Post
September 26, 2022
Antimicrobial resistance is a major global problem. Today, drug resistant infections kill an estimated 1.27 million people per year, and low- and middle-income countries bear the brunt of AMR-related deaths and illness. Changing how we buy antimicrobials can help solve the problem.